Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BE Labs (Bio-Engineered Labs) is a biotechnology company specializing in the development of advanced drug delivery systems designed to enhance the bioavailability of lipophilic compounds. The company's core technology, SENDS (Self-Emulsifying Nano-Delivery System), utilizes a proprietary blend of surfactants and oils to create stable, water-soluble nano-emulsions that significantly improve the absorption of active ingredients. While the company has a strong focus on cannabinoid-based formulations, its platform is applicable to a wide range of pharmaceuticals, nutraceuticals, and vitamins. BE Labs operates as a technology provider and contract manufacturer, offering formulation development, analytical testing, and commercial-scale production services to partners in the healthcare and wellness industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BE Labs.